Systems biologist Steven Wiley says advancements in two areas—single-cell biology and CRISPR—are poised to transform research.  

To advance the possibility of off-the-shelf cardiac cell therapies, scientists devise an engineered cardiac stem cell that avoids stimulating a detrimental immune attack.

Half of early-career researchers say they’d participated in the peer review process with their mentors without getting credit.

The animals showed changes in both slow wave and rapid eye movement sleep.

The FDA recently cleared the way for marketing of the genetically modified product. Texas A&M’s Keerti Rathore speaks with The Scientist about why and how it was developed.

In light of recent reports of electronic-cigarette–related illness and death, UNC Chapel Hill professor Robert Tarran discusses the dangerous effects of e-liquids on the lungs.

Two coauthors of a new study discuss their findings about nearly 170 facilities in the southwestern US selling unproven therapies—and what should be done about them.

Johns Hopkins’s Ted Dawson discusses his lab’s demonstration that misfolded α-synuclein can move from the stomach to the brain and cause physical and cognitive symptoms.

Microbiologist Nick Loman talks about the power of artificial intelligence and the best way to use it.